Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (7) , 1019-1022
- https://doi.org/10.1016/0959-8049(94)90135-x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancerEuropean Journal Of Cancer, 1993
- Phase II study of oral miltefosine in patients with squamous cell head and neck cancerEuropean Journal Of Cancer, 1993
- Phase II study of miltefosine (Hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult— An EORTC Soft Tissue and Bone Sarcoma Group studyEuropean Journal Of Cancer, 1993
- Hexadecylphosphocholine: Preclinical and the first clinical results of a new antitumor drugLipids, 1991
- Phase I Study of Weekly Oral Miltefosine (Hexadecyl-Phosphocholine) in Cancer PatientsOncology Research and Treatment, 1991
- Hexadecylphosphocholine: a new and selective antitumor drugCancer Treatment Reviews, 1990
- Effect of ether lipids of mousé granulocyte-macrophage progenitor cellsCancer Chemotherapy and Pharmacology, 1989
- Hexadecylphosphocholine, a New Ether Lipid Analogue Studies on the Antineoplastic Activity in Vitro and in VivoActa Oncologica, 1988
- Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)European Journal of Cancer and Clinical Oncology, 1988
- Membrane targets in cancer chemotherapy: A report of a one day symposium of the EORTC-PAM group meeting held at the Centre Antoine Lacassagne, Nice, France, 4 December 1987European Journal of Cancer and Clinical Oncology, 1988